Views & Analysis Digital Health Round-up: Teva looks to AI for drug repurposi... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News ESMO26: Roche's KRAS drug tops approved drugs in NSCLC In the Krascedo-1 trial, Roche's KRAS G12C inhibitor divarasib met high expectations, with a head-to-head win over Lumakras and Krazati.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
